Clinical Trial Update: An Evaluation of Safety and Efficacy of Anecortave Acetate Versus Placebo in Patients With Subfoveal CNV Due to Exudative AMD [Phase 3]

View source ↗

Summary

Phase 3 trial evaluating safety and efficacy of Anecortave acetate versus placebo in subfoveal CNV due to exudative age-related macular degeneration has complet…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Age-related Macular Degeneration

Drugs mentioned

• anecortave acetate (anecortave acetate)

Snippet

Sponsor: Alcon Research | Conditions: Macular Degeneration, Maculopathy, Age-Related | Phase 3 | Status: COMPLETED